Impact Biomedical (IBO) Interest Expenses (2022 - 2026)

Impact Biomedical's Interest Expenses history runs 5 years deep, the most recent figure standing at $11.0 million for Q1 2026.

• Quarterly Interest Expenses rose 760.84% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (up 760.84% YoY) and the FY2025 annual result came in at $11.3 million, up 917.88% from the prior year.
• Interest Expenses was $11.0 million for Q1 2026 at Impact Biomedical, up from $417000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $11.0 million in Q1 2026 and bottomed at $92000.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $1.1 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses soared 1109.78% — and 2024, when it changed 0.0%.
• Impact Biomedical's Interest Expenses stood at $99000.0 in 2022, then gained by 26.26% to $125000.0 in 2023, then surged by 116.0% to $270000.0 in 2024, then surged by 54.44% to $417000.0 in 2025, then surged by 2546.52% to $11.0 million in 2026.
• Business Quant data shows IBO's Interest Expenses at $11.0 million in Q1 2026, $417000.0 in Q4 2025, and $1.1 million in Q3 2025.